#Antibody

Monica Gandhi MD, MPH

MonicaGandhi9

Thank you for sending me this paper in Science Immunology (one of many now) showing strong immunity developing in health care workers even after asymptomatic or mild infection. Wanted to

Ryan McNamara 🧬

Ryan_Mac_Phd

The J&J vaccine reportedly confers 85% protection after 1 month. Some suggest this could be improved with a booster. About that...J&J vaccine uses a replication-incompetent adenovirus (Ad26) to deliver the

Dr Zoë Hyde

DrZoeHyde

(1/5) Study of #SARSCoV2 antibody prevalence in children from Bavaria, Germany, showing infections in children were 6 times higher than PCR tests suggested, and that young & older children were

Christian Gaebler

c_gaebler

Ever since the US crossed 100k daily #COVID19 cases, we are even more excited to share positive news. Our newest preprint shows that #SARSCoV2 B cell immune memory not only

Atomsk's Sanakan

AtomsksSanakan

Sweden's government is to the COVID-19 pandemic what South Africa's (Mbeki) government was to the AIDS pandemicThey ditched mainstream, evidence-based advice. So their people diedhttps://link.springer.com/article/10.1007/s10461-009-

Eric Feigl-Ding

DrEricDing

Huge ANTIBODY study in NYC among 40,000 health care professionals. Key #COVID19 findings:13.7% were seropositive. Of 6078 w/ previous PCR testing, 34.8% were PCR positive. Of previous PCR-positives, 6.5% had

brendan

brendan_49

The rationale for ROR1 as CAR-T target:1) Expression restricted to fetus and tumors. If ADC's are safe CARs should be too.2) ADCs nabbed monotherapy CRs in MCL.3) Diverse tumors evolve

Gupta Lab, Cambridge

GuptaR_lab

B1.1.7 has more than 20 changes in genetic code, of which 8 are in the Spike protein (shown below). Spike is the target of many of our immune and vaccine

Liz Johnson

wired4story

The past 8 years has seen a lot of targeted therapies for ER+ breast cancer.#MBCImpactNJ @komennewjersey Immunotherapy is being combined with CDK4/6 with some success in the lab. Not yet

HSE Ireland

HSELive

THREAD: SCOPI: #COVID19 antibody research study results. @hpscireland and @nvrlucdireland have completed their study about #coronavirus infection in Ireland The main aim was to find out how widely #coronavirus has

Aaron Goodman

AaronGoodman33

All FDA Antibody Drug Conjugates Heme MaligTweetorial#Goodman_hemeAntibody+Linker+Chemo/toxinMOAFDA approvals (trial)tox (last tweet)Gemtuzumab ozogamicinanti-CD33+calicheamicin (DNA breaker)Frontline AML+7+3 (ALFA,AML15)Pediatric induction

Bloom Lab

jbloom_lab

Our new study led by @khdcrawford in collaboration with @HelenChuMD looks at the dynamics of neutralizing antibodies in the 3-4 months following recovery from infection with #SARSCoV2 (1/9):https://www.medrxiv.org/content/10.1101/2020.08.06

Prof. Akiko Iwasaki

VirusesImmunity

What aspects of antibody responses determine the outcome of #COVID19? In this new preprint by @carolilucas @sneakyvirus1 et al., we found that the early timing of antibody response (before 14

SirtSix

SirtSix

Two papers out from $REGN in @ScienceMagazine describing the company's investigational antibody cocktail approach to protect against #COVID19. Paper 1 describes pairs of highly potent (pM neutralization potency) non-competing mAbs

Mac n’ Chise 🧬🧫🦠

sailorrooscout

A very encouraging study done on our mRNA vaccines! Pfizer and Moderna vaccines provided strong immune responses against variant B.1.351 first identified in South Africa in those who recovered from

Tom

TomboxaneA2

Haembase updated with the new BSH Hairy Cell Leukaemia guideline, why not try the questions in the thread below before taking a look?https://haembase.com/hairy-cell-leukaemiahttps://onlinelibrary.wiley.com/doi/epdf/10.1111/bjh.17055#haemato

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.